Amphastar Pharmaceuticals, Inc.
AMPH
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary rā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
11 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$27.74
Price+1.50%
$0.41
1Y
Price
Market Cap
$1.275b
Small
Price/Earnings 3y Avg5y Avg
12.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+21.9%
EBITDA Margin+9.0%
Net Profit Margin+24.6%
Free Cash Flow Margin+21.9%
EBITDA Margin+9.0%
Net Profit Margin+24.6%
Free Cash Flow MarginRevenue
$723.305m
-1.2%
1y CAGR+13.8%
3y CAGR+13.9%
5y CAGREarnings
$111.629m
-30.0%
1y CAGR+12.2%
3y CAGR+20.9%
5y CAGREPS
$2.26
-26.1%
1y CAGR+13.7%
3y CAGR+20.1%
5y CAGRBook Value
$776.746m
$1.666b
Assets$889.476m
Liabilities$656.773m
DebtDebt to Assets
39.4%
3x
Debt to EBITDAFree Cash Flow
$113.255m
-34.3%
1y CAGR+35.8%
3y CAGR+24.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company